Now showing items 1-12 of 12
| Title | Author(s) | Journal | Issue Date | Type |
|---|---|---|---|---|
| Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine | Tang, M. W.; Rhee, S. Y.; Bertagnolio, S.; Ford, N.; Holmes, S.; Sigaloff, K. C.; Hamers, R. L.; Rinke de Wit, T. F.; Fleury, H. J.; Kanki, P. J.; Ruxrungtham, K.; Hawkins, C. A.; Wallis, C. L.; Stevens, W.; van Zyl, G. U.; Manosuthi, W.; Hosseinipour, M. C.; Ngo-Giang-Huong, N.; Belec, L.; Peeters, M.; Aghokeng, A.; Bunupuradah, T.; Burdah, S.; Cane, P.; Cappelli, G.; Charpentier, C.; Dagnra, A. Y.; Deshpande, A. K.; El-Katib, Z.; Eshleman, S. H.; Fokam, J.; Gody, J. C.; Katzenstein, D.; Koyalta, D. D.; Kumwenda, J. J.; Lallemant, M.; Lynen, L.; Marconi, V. C.; Margot, N. A.; Moussa, S.; Ndung'u, T.; Nyambi, P. N.; Orrell, C.; Schapiro, J. M.; Schuurman, R.; Sirivichayakul, S.; Smith, D.; Zolfo, M.; Jordan, M. R.; Shafer, R. W. | Journal of Infectious Diseases | 2013 | Article |
| Risk factors of treatment-limiting anemia after substitution of zidovudine for stavudine in HIV-infected adult patients on antiretroviral treatment | Phe, T.; Thai, S.; Veng, C.; Sok, S.; Lynen, L.; van Griensven, J. | PLoS ONE | 2013 | Article-E |
| Prevalence of HIV-associated metabolic abnormalities among patients taking first-line antiretrovial therapy in Uganda | Omech, B.; Sempa, J.; Castelnuovo, B.; Opio, K.; Otim, M.; Mayanja-Kizza, H.; Colebunders, R.; Manabe, Y. C. | ISRN AIDS | 2012 | Article-E |
| What is the optimal first line antiretroviral therapy in resource-limited settings? [comment] | Kenyon, C.; Colebunders, R. | PLoS Medicine | 2012 | Comment-E |
| Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa | Okomo, U.; Togun, T.; Oko, F.; Peterson, K.; Townend, J.; Peterson, I.; Jaye, A. | BMC Pediatrics | 2012 | Article-E |
| Adoption of new HIV treatment guidelines and drug substitutions within first-line as a measure of quality of care in rural Lesotho: health centers and hospitals compared | Labhardt, N. D.; Sello, M.; Lejone, T.; Ehmer, J.; Mokhantso, M.; Lynen, L.; Pfeiffer, K. | Tropical Medicine and International Health | 2012 | Article |
| Reducing pediatric HIV infection: estimating mother to child transmission rates in a program setting in Zambia | Torpey, K.; Kasonde, P.; Kabaso, M.; Weaver, M. A.; Bryan, G.; Mukonka, V.; Bweupe, M.; Zimba, C.; Mwale, F.; Colebunders, R. | Journal of Acquired Immune Deficiency Syndromes | 2010 | Article |
| Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006 | Vercauteren, J.; Derdelinckx, I.; Sasse, A.; Bogaert, M.; Ceunen, H.; De Roo, A.; De Wit, S.; Deforche, K.; Echahidi, F.; Fransen, K.; Goffard, J. C.; Goubau, P.; Goudeseune, E.; Yombi, J. C.; Lacor, P.; Liesnard, C.; Moutschen, M.; Pierard, D.; Rens, R.; Schrooten, Y.; Vaira, D.; Van den Heuvel, A.; Van der Gucht, B.; Van Ranst, M.; Van Wijngaerden, E.; Vandercam, B.; Vekemans, M.; Verhofstede, C.; Clumeck, N.; Vandamme, A. M.; Van Laethem, K. | AIDS Research and Human Retroviruses | 2008 | Article |
| Zidovudine against mother-to-child HIV transmission [letter] | Colebunders, R.; Coppieters, Y. | Tropical Medicine and International Health | 1999 | Letter |
| Efficacy and safety of combination therapy with delavirdine and zidovudine: a European/Australian phase II trial | Been-Tiktak, A. M. M.; Boucher, C. A. B.; Brun-Vezinet, F.; Joly, V.; Mulder, J. W.; Jost, J.; Cooper, D. A.; Moroni, M.; Gatell, J. M.; Staszewski, S.; Colebunders, R.; Stewart, G. J.; Hawkins, D. A.; Johnson, M. A.; Parkin, J. M.; Kennedy, D. H.; Hoy, J. F.; Borleffs, J. C. C. | International Journal of Antimicrobial Agents | 1999 | Article |
| Korte kuren met AZT | Vandenbruaene, M. | SOA AIDS Info | 1998 | Article |
| Ethical issues in the use of zidovudine to reduce vertical transmission of HIV [letter] | De Roo, A.; Colebunders, R. | New England Journal of Medicine | 1995 | Letter |
Now showing items 1-12 of 12